BMRN vs VSTD · P/E 40, rev $2.85B vs rev $12.8M
Biomarin Pharmaceutical Inc (BMRN) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the BMRN and VSTD stock pages for the full models.
Not investment advice.